Mendus AB (publ) (IMMU) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, Mendus AB (publ) (IMMU) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.80 Million ≈ $-2.24 Million USD) by net assets (Skr565.14 Million ≈ $60.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mendus AB (publ) net asset quality index to measure how much of total assets are equity-financed.

Mendus AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Mendus AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IMMU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Mendus AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mendus AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Atakule Gayrimenkul Yatirim Ortakligi AS IS:AGYO	0.006x
Telcoware KO:078000	0.157x
Marketwise Inc NASDAQ:MKTW	0.009x
CANTOURAGE GROUP SE O.N. F:HIGH	N/A
Cokal Ltd AU:CKA	0.410x
Mad Paws Holdings Ltd AU:MPA	0.133x
HPQ SILICON INC. F:O08	-0.051x
Native Mineral Resources Holdings Ltd AU:NMR	-0.815x

Annual Cash Flow Conversion Efficiency for Mendus AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Mendus AB (publ) worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr585.07 Million ≈ $62.96 Million	Skr-81.53 Million ≈ $-8.77 Million	-0.139x	-12.85%
2024-12-31	Skr645.15 Million ≈ $69.43 Million	Skr-79.67 Million ≈ $-8.57 Million	-0.123x	+46.53%
2023-12-31	Skr704.73 Million ≈ $75.84 Million	Skr-162.76 Million ≈ $-17.52 Million	-0.231x	-8.67%
2022-12-31	Skr514.44 Million ≈ $55.36 Million	Skr-109.33 Million ≈ $-11.77 Million	-0.213x	-1.12%
2021-12-31	Skr656.74 Million ≈ $70.68 Million	Skr-138.03 Million ≈ $-14.85 Million	-0.210x	-145.38%
2020-12-31	Skr661.09 Million ≈ $71.14 Million	Skr-56.63 Million ≈ $-6.09 Million	-0.086x	+83.98%
2019-12-31	Skr272.78 Million ≈ $29.36 Million	Skr-145.81 Million ≈ $-15.69 Million	-0.535x	-107.36%
2018-12-31	Skr406.04 Million ≈ $43.70 Million	Skr-104.67 Million ≈ $-11.26 Million	-0.258x	-5.20%
2017-12-31	Skr189.56 Million ≈ $20.40 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.245x	+25.64%
2016-12-31	Skr102.39 Million ≈ $11.02 Million	Skr-33.74 Million ≈ $-3.63 Million	-0.330x	-14.00%
2015-12-31	Skr139.18 Million ≈ $14.98 Million	Skr-40.23 Million ≈ $-4.33 Million	-0.289x	+53.42%
2014-12-31	Skr64.63 Million ≈ $6.95 Million	Skr-40.10 Million ≈ $-4.32 Million	-0.621x	-570.22%
2013-12-31	Skr100.24 Million ≈ $10.79 Million	Skr-9.28 Million ≈ $-998.77K	-0.093x	+68.12%
2012-12-31	Skr24.60 Million ≈ $2.65 Million	Skr-7.15 Million ≈ $-769.03K	-0.290x	+31.50%
2011-12-31	Skr7.63 Million ≈ $820.73K	Skr-3.23 Million ≈ $-347.98K	-0.424x	+0.26%
2010-12-31	Skr3.92 Million ≈ $421.83K	Skr-1.67 Million ≈ $-179.31K	-0.425x	--

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$43.53 Million

Skr404.47 Million SEK

Market Cap Rank

#22372 Global

#425 in Sweden

Share Price

Skr6.60

Change (1 day)

-4.90%

52-Week Range

Skr3.96 - Skr10.02

All Time High

Skr737.49